Technivie is being considered for BC PharmaCare coverage. Therefore, PharmaCare is collecting input between Wednesday, January 20th, and Wednesday February 17, 2016 AT MIDNIGHT—now—for this process.

If you are a BC resident and answer YES to any of the following questions, BC’s health care system wants to hear from you:

• Do you have hep C?
• Are you a caregiver to someone who has hep C?
• Does your patient group represent patients who have hep C AND have you registered with PharmaCare to give input? (Learn more about registering your organization).

A link to BC PharmaCare’s questionnaires for Technivie can be found at PharmaCare’s Your Voice (scroll down towards the bottom of the page).

About Technivie

Information about Technivie can be found at  Technivie (Ombitasvir / Paritaprevir / Ritonavir) Facts, BC PharmaCare Drug Information, or in CTAC’s Technivie Youtube video. CTAC’s video uses the name 2D instead of Technivie. It is the same treatment, its Canadian brand name just hadn’t been assigned when the video was created in September 2015.

For more information, please contact BC PharmaCare’s Your Voice or the Hepatitis C Treatment Information Project.